Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anirban Chatterjee

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
The Lancet. Oncology|June 22, 2014
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trialSusan J Dutton, David R Ferry, Jane M Blazeby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2017
Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal CancerRussell D Petty, Asa Dahle-Smith, David A J Stevenson, et al.
BMJ Open|April 19, 2022
A pilot multicentre cluster randomised trial to compare the effect of trauma life support training programmes on patient and provider outcomesMartin Gerdin Wärnberg, Johanna Berg, Prashant Bhandarkar, et al.
Journal of Indian Society of Periodontology|August 12, 2022
ISP Good Clinical Practice Recommendations for the management of Dentin HypersensitivityVishakha Grover, Ashish Kumar, Ashish Jain, et al.
JAMA Oncology|May 13, 2021
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical TrialPeter S Hall, Daniel Swinson, David A Cairns, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
The Lancet. Oncology|June 22, 2014
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trialSusan J Dutton, David R Ferry, Jane M Blazeby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2017
Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal CancerRussell D Petty, Asa Dahle-Smith, David A J Stevenson, et al.
BMJ Open|April 19, 2022
A pilot multicentre cluster randomised trial to compare the effect of trauma life support training programmes on patient and provider outcomesMartin Gerdin Wärnberg, Johanna Berg, Prashant Bhandarkar, et al.
Journal of Indian Society of Periodontology|August 12, 2022
ISP Good Clinical Practice Recommendations for the management of Dentin HypersensitivityVishakha Grover, Ashish Kumar, Ashish Jain, et al.
JAMA Oncology|May 13, 2021
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical TrialPeter S Hall, Daniel Swinson, David A Cairns, et al.
Pageof 11